For the random forest on the marginal distributions, we include tumor dose, tumor size GTV, and pre‐treatment AFP in the efficacy model, and liver dose, pre‐treatment ALBI, tumor size GTV, and prior liver directed therapy in the toxicity model. This evidence concerns the gene AFP and neoplasm.